Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$337K Buy
931
+40
+4% +$13.7K 0.11% 128
2026
Q1
$313K Buy
891
+14
+2% +$4.99K 0.11% 114
2025
Q4
$287K Hold
877
0.1% 127
2025
Q3
$247K Buy
877
+19
+2% +$5.51K 0.09% 149
2025
Q2
$240K Buy
858
+5
+0.6% +$1.42K 0.1% 153
2025
Q1
$266K Buy
853
+14
+2% +$4.13K 0.13% 119
2024
Q4
$219K Sell
839
-482
-36% -$143K 0.1% 152
2024
Q3
$426K Buy
1,321
+4
+0.3% +$1.31K 0.2% 78
2024
Q2
$411K Sell
1,317
-176
-12% -$51.7K 0.22% 76
2024
Q1
$424K Sell
1,493
-9
-0.6% -$2.63K 0.22% 74
2023
Q4
$433K Sell
1,502
-2
-0.1% -$545 0.24% 78
2023
Q3
$404K Buy
1,504
+19
+1% +$4.74K 0.26% 82
2023
Q2
$330K Buy
1,485
+166
+13% +$38.5K 0.21% 90
2023
Q1
$319K Buy
1,319
+168
+15% +$41.2K 0.21% 97
2022
Q4
$302K Sell
1,151
-6
-0.5% -$1.61K 0.21% 98
2022
Q3
$261K Buy
1,157
+64
+6% +$15.5K 0.21% 98
2022
Q2
$266K Buy
1,093
+55
+5% +$13.5K 0.2% 96
2022
Q1
$251K Buy
1,038
+63
+6% +$14.5K 0.22% 90
2021
Q4
$219K Buy
975
+25
+3% +$5.28K 0.19% 98
2021
Q3
$202K Buy
+950
New +$219K 0.23% 89

Other funds holding AMGN

Five Oceans Advisors's AMGN Position: Q2 2026 in Review

Five Oceans Advisors increased its Amgen (AMGN) stake by 4.5% in Q2 2026, buying an estimated $13.7K and bringing the position to 931 shares worth $337K. The position accounts for 0.11% of the portfolio, ranked #128.

Five Oceans Advisors first reported a position in AMGN in Q3 2021 and has held it in 20 quarters since. The position peaked at $433K in Q4 2023. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Five Oceans Advisors held 931 shares of Amgen worth $337K as of Q2 2026.
  • Five Oceans Advisors bought 40 Amgen shares in Q2 2026, an estimated $13.7K.
  • Amgen made up 0.11% of Five Oceans Advisors's portfolio in Q2 2026, its #128 holding.
  • Five Oceans Advisors first reported a position in Amgen in Q3 2021 and has held it in 20 quarters since.
  • Five Oceans Advisors's Amgen position peaked at $433K in Q4 2023.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Five Oceans Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.